BTAF:CRYPTOCAPMarket Cap BTAF, $ Analysis
Data as of 2026-06-07 - not real-time
$61.34
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
British American Tobacco trades around $61, comfortably above its 50‑day and 200‑day moving averages but just shy of the 20‑day average, indicating a short‑term pull‑back within a longer‑term uptrend. The bullish trend direction is tempered by a bearish MACD crossover and a neutral RSI near 50, while volume has been slipping, suggesting limited buying pressure. Fundamentally, the company delivers a robust 5.45% dividend yield on a 68.8% payout ratio, supported by strong operating margins and solid cash flow, and its low beta points to modest market‑wide volatility.
Regulatory headwinds remain a concern for the tobacco sector, yet the firm’s diversified geographic footprint and defensive consumer‑defensive positioning provide a cushion. High 30‑day price volatility and a recent max drawdown of roughly 16% add a layer of price risk, but the combination of stable earnings, attractive yield, and defensive sector dynamics makes the stock a reasonable hold for income‑focused investors.
Regulatory headwinds remain a concern for the tobacco sector, yet the firm’s diversified geographic footprint and defensive consumer‑defensive positioning provide a cushion. High 30‑day price volatility and a recent max drawdown of roughly 16% add a layer of price risk, but the combination of stable earnings, attractive yield, and defensive sector dynamics makes the stock a reasonable hold for income‑focused investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term resistance and below 20‑day SMA
- Bearish MACD signal and decreasing volume
- High dividend yield providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained bullish trend above 50‑day and 200‑day SMA
- Strong cash generation and comfortable payout ratio
- Defensive sector positioning with global diversification
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Stable earnings and attractive dividend yield
- Low beta indicating resilience to market swings
- Long‑term defensive consumer‑defensive exposure despite regulatory headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth0.10%
Profit Margin30.32%
P/E Ratio13.1
ROE15.82%
ROA5.34%
Debt/Equity72.84
P/B Ratio2.2
Op. Cash Flow$6.3B
Free Cash Flow$3.0B
Technical Analysis
TrendBullish
RSI48.3
Support$57.29
Resistance$69.57
MA 20$63.42
MA 50$60.69
MA 200$57.79
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Fair Value$3.91
GradeFair
TypeValue
Dividend Yield5.45%
Risk Assessment
Beta0.45
Volatility57.27%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.